Defining the optimal interval between liver biopsies for clinical decision making regarding initiating HCV therapy: rate of disease progression in HCV disease: Jean-Pierre Zarski, Centre Hospitalier Universitaire de Grenoble, Grenoble France; Richard Garcia-Kennedy, Pacific Medical Center, San Francisco; Jean-Pierre Bronowicki, Centre Hospitalier Universitaire, Nancy France; John Mac Hutchinson, Scripps Clinic, San Diego; Enkelejda Hodaj, Centre Hospitalier Universitaire, Grenoble France; Truta Brandusa, Teresa Wright, Veteran's American Hosp, San Francisco; Robert Gish, Pacific Medical Ctr, San Francisco